Genome-wide gene-based analysis suggests an association between Neuroligin 1 (NLGN1) and post-traumatic stress disorder

Translational Psychiatry

Volumn 6, Issue 5, 2016, Pages

  Kilaru, V ^a   Iyer, S V ^b   Almli, L M ^a   Stevens, J S ^a   Lori, A ^a   Jovanovic, T ^a   Ely, T D ^a   Bradley, B ^a,c   Binder, E B ^a,d   Koen, N ^e   Stein, D J ^e   Conneely, K N ^a   Wingo, A P ^a,c   Smith, A K ^a   Ressler, K J ^a,f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MANIPAL SCHOOL OF LIFE SCIENCES   (India)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; NERVE CELL ADHESION MOLECULE; NEUROLIGIN 1; ZNRD1AS GENE PRODUCT, HUMAN;

ADULT; AFRICAN AMERICAN; AMYGDALA; BRAIN; CAUCASIAN; DIAGNOSTIC IMAGING; FACIAL EXPRESSION; FACIAL RECOGNITION; FEAR; FEMALE; FUNCTIONAL NEUROIMAGING; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STARTLE REFLEX; TEMPORAL LOBE; THALAMUS; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; AMYGDALA; BRAIN; CELL ADHESION MOLECULES, NEURONAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACIAL EXPRESSION; FACIAL RECOGNITION; FEAR; FEMALE; FUNCTIONAL NEUROIMAGING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; REFLEX, STARTLE; STRESS DISORDERS, POST-TRAUMATIC; TEMPORAL LOBE; THALAMUS; YOUNG ADULT;

EID: 84994620749     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/TP.2016.69     Document Type: Article

References (83)

1. Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005; 352: 2515-2523.
2. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52: 1048-1060.
3. True WR, Rice J, Eisen SA, Heath AC, Goldberg J, Lyons MJ et al. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 1993; 50: 257-264.
4. Stein MB, Jang KL, Taylor S, Vernon PA, Livesley WJ. Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: A twin study. Am J Psychiatry 2002; 159: 1675-1681.
5. Almli LM, Fani N, Smith AK, Ressler KJ. Genetic approaches to understanding post-traumatic stress disorder. Int J Neuropsychopharmacol 2014; 17: 355-370.
6. Cornelis MC, Nugent NR, Amstadter AB, Koenen KC. Genetics of post-traumatic stress disorder: Review and recommendations for genome-wide association stu¬dies. Curr Psychiatry Rep 2010; 12: 313-326.
7. Logue MW, Amstadter AB, Baker DG, Duncan L, Koenen KC, Liberzon I et al. The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic stress disorder enters the age of large-scale genomic collaboration. Neuropsychopharmacology 2015; 40: 2287-2289.
8. Logue MW, Baldwin C, Guffanti G, Melista E, Wolf EJ, Reardon AF et al. A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psy¬chiatry 2013; 18: 937-942.
9. Guffanti G, Galea S, Yan L, Roberts AL, Solovieff N, Aiello AE et al. Genome-wide association study implicates a novel RNA gene, the lincRNA AC068718.1, as a risk factor for post-traumatic stress disorder in women. Psychoneuroendocrinology 2013; 38: 3029-3038.
10. Almli LM, Stevens JS, Smith AK, Kilaru V, Meng Q, Flory J et al. A genome-wide identified risk variant for PTSD is a methylation quantitative trait locus and confers decreased cortical activation to fearful faces. Am J Med Genet B 2015; 168B: 327-336.
11. Xie PX, Kranzler HR, Yang C, Zhao HY, Farrer LA, Gelernter J. Genome-wide association study identifies new susceptibility loci for posttraumatic stress dis¬order. Biol Psychiatry 2013; 74: 656-663.
12. Nievergelt CM, Maihofer AX, Mustapic M, Yurgil KA, Schork NJ, Miller MW et al. Genomic predictors of combat stress vulnerability and resilience in US Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrino 2015; 51: 459-471.
13. Neale BM, Sham PC. The future of association studies: Gene-based analysis and replication. Am J Hum Genet 2004; 75: 353-362.
14. Jorgenson E, Witte JS. A gene-centric approach to genome-wide association studies. Nat Rev Genet 2006; 7: 885-891.
15. Wang L, Jia P, Wolfinger RD, Chen X, Zhao Z. Gene set analysis of genome-wide association studies: Methodological issues and perspectives. Genomics 2011; 98: 1-8.
16. Li MX, Gui HS, Kwan JS, Sham PC. GATES: A rapid and powerful gene-based association test using extended Simes procedure. Am J Hum Genet 2011; 88: 283-293.
17. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM et al. A versatile gene-based test for genome-wide association studies. Am J Hum Genet 2010; 87: 139-145.
18. Huang H, Chanda P, Alonso A, Bader JS, Arking DE. Gene-based tests of asso¬ciation. PLoS Genet 2011; 7: E1002177.
19. Chanda P, Huang H, Arking DE, Bader JS. Fast association tests for genes with FAST. PLoS One 2013; 8: E68585.
20. Stevens JS, Jovanovic T, Fani N, Ely TD, Glover EM, Bradley B et al. Disrupted amygdala-prefrontal functional connectivity in civilian women with posttraumatic stress disorder. J Psychiatr Res 2013; 47: 1469-1478.
21. Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB et al. Exag¬gerated amygdala response to masked facial stimuli in posttraumatic stress dis¬order: A functional MRI study. Biol Psychiatry 2000; 47: 769-776.
22. Jovanovic T, Blanding NQ, Norrholm SD, Duncan E, Bradley B, Ressler KJ. Child¬hood abuse is associated with increased startle reactivity in adulthood. Depress Anxiety 2009; 26: 1018-1026.
23. Grillon C. Models and mechanisms of anxiety: Evidence from startle studies. Psychopharmacology (Berl) 2008; 199: 421-437.
24. Gillespie CF, Bradley B, Mercer K, Smith AK, Conneely K, Gapen M et al. Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry 2009; 31: 505-514.
25. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 2013; 16: 33-41.
26. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008; 299: 1291-1305.
27. Gillespie CF, Bradley RG, Mercer K, Smith AK, Conneely K, Gapen M et al. Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry 2009; 31: 505-514.
28. Falsetti SA, Resnick HS, Resick PA, Kilpatrick DG. The Modified PTSD Symptom Scale: A brief self-report measure of posttraumatic stress disorder. Behav Therap 1993; 16: 161-162.
29. Foa EB, Tolin DF. Comparison of the PTSD symptom scale-interview version and the clinician administered PTSD scale. J Traum Stress 2000; 13: 181-191.
30. Association AP. Diagnostic and Statistical Manual of Mental DisordersFouth Edition Text Revision (DSM-IV-TR). American Psychiatric Association: Washington, DC, USA, 2000.
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
32. Pluzhnikov A, Below JE, Konkashbaev A, Tikhomirov A, Kistner-Griffin E, Roe CA et al. Spoiling the whole bunch: Quality control aimed at preserving the integrity of high-throughput genotyping. The Am J Hum Genet 2010; 87: 123-128.
33. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association stu¬dies. Nat Genet 2006; 38: 904-909.
34. Visscher PM. Handbook on Analyzing Human GeneticData: ComputationalApproaches and Software, Lin S, Zhao H (eds). Blackwell Publishing Inc.: Malden, MA, USA, 2010.
35. Stephens M. A unified framework for association analysis with multiple related phenotypes. PLoS One 2013; 8: E65245.
36. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986; 73: 751-754.
37. Koen N, Wyatt GE, Williams JK, Zhang M, Myer L, Zar HJ et al. Intimate partner violence: associations with low infant birthweight in a South African birth cohort. Metab Brain Dis 2014; 29: 281-299.
38. Zar HJ, Barnett W, Myer L, Stein DJ, Nicol MP. Investigating the early-life deter¬minants of illness in Africa: The Drakenstein Child Health Study. Thorax 2015; 70: 592-594.
39. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33
40. Stevens JS, Almli LM, Fani N, Gutman DA, Bradley B, Norrholm SD et al. PACAP receptor gene polymorphism impacts fear responses in the amygdala and hip¬pocampus. Proc Natl Acad Sci USA 2014; 111: 3158-3163.
41. Almli LM, Stevens JS, Smith AK, Kilaru V, Meng Q, Flory J et al. A genome-wide identified risk variant for PTSD is a methylation quantitative trait locus and confers decreased cortical activation to fearful faces. Am J Med Genet B 2015; 168B: 327-336.
42. Andero R, Brothers SP, Jovanovic T, Chen YT, Salah-Uddin H, Cameron M et al. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med 2013; 5: 188ra173-188ra173.
43. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. NeuroImage 2005; 25: 1325-1335.
44. Song X-W, Dong Z-Y, Long X-Y, Li S-F, Zuo X-N, Zhu C-Z et al. REST: A toolkit for resting-state functional magnetic resonance imaging data processing. PLoS One 2011; 6: E25031.
45. Bennett CM, Wolford GL, Miller MB. The principled control of false positives in neuroimaging. Social Cognitive and Affective Neuroscience 2009; 4: 417-422.
46. Jovanovic T, Norrholm SD, Blanding NQ, Davis M, Duncan E, Bradley B et al. Impaired fear inhibition is a biomarker of PTSD but not depression. Depress Anxiety 2010; 27: 244-251.
47. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367.
48. Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455: 903-911.
49. Lise MF, El-Husseini A. The neuroligin and neurexin families: From structure to function at the synapse. Cell Mol Life Sci 2006; 63: 1833-1849.
50. Levinson JN, El-Husseini A. Building excitatory and inhibitory synapses: Balancing neuroligin partnerships. Neuron 2005; 48: 171-174.
51. Blundell J, Blaiss CA, Etherton MR, Espinosa F, Tabuchi K, Walz C et al. Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci 2010; 30: 2115-2129.
52. Feusner JD, Hembacher E, Phillips KA. The mouse who couldn’t stop washing: Pathologic grooming in animals and humans. CNS Spectrum 2009; 14: 503-513.
53. Ochsner KN, Ray RD, Cooper JC, Robertson ER, Chopra S, Gabrieli JD et al. For better or for worse: Neural systems supporting the cognitive down-and up-reg-ulation of negative emotion. Neuroimage 2004; 23: 483-499.
54. Kim S, Hamann SB. Neural correlates of positive and negative emotion regulation. J Cogn Neurosci 2007; 19: 776-798.
55. Ueda K, Okamoto Y, Okada G, Yamashita H, Hori T, Yamawaki S. Brain activity during expectancy of emotional stimuli: An fMRI study. Neuroreport 2003; 14: 51-55.
56. Nitschke JB, Mackiewicz KL. Prefrontal and anterior cingulate contributions to volition in depression. Int Rev Neurobiol 2005; 67: 73-94.
57. Fani N, Jovanovic T, Ely TD, Bradley B, Gutman D, Tone EB et al. Neural correlates of attention bias to threat in post-traumatic stress disorder. Biol Psychol 2012; 90: 134-142.
58. Fairhall SL, Ishai A. Effective connectivity within the distributed cortical network for face perception. Cereb Cortex 2007; 17: 2400-2406.
59. Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: An fMRI study in severe major depressive dis¬order. Biol Psychiatry 2008; 63: 369-376.
60. Haxby JV, Hoffman EA, Gobbini MI. The distributed human neural system for face perception. Trends Cogn Sci 2000; 4: 223-233.
61. Lee Y, Lopez DE, Meloni EG, Davis M. A primary acoustic startle pathway: Obli¬gatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J Neurosci 1996; 16: 3775-3789.
62. Tsvetkov E, Carlezon WA, Benes FM, Kandel ER, Bolshakov VY. Fear conditioning occludes LTP-induced presynaptic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala. Neuron 2002; 34: 289-300.
63. McKernan MG, Shinnick-Gallagher P. Fear conditioning induces a lasting poten¬tiation of synaptic currents in vitro. Nature 1997; 390: 607-611.
64. Kim J, Lee S, Park K, Hong I, Song B, Son G et al. Amygdala depotentiation and fear extinction. Proc Natl Acad Sci USA 2007; 104: 20955-20960.
65. Hong I, Song B, Lee S, Kim J, Kim J, Choi S. Extinction of cued fear memory involves a distinct form of depotentiation at cortical input synapses onto the lateral amygdala. Eur J Neurosci 2009; 30: 2089-2099.
66. Park S, Lee S, Kim J, Choi S. Ex vivo depotentiation of conditioning-induced potentiation at thalamic input synapses onto the lateral amygdala requires GluN2B-containing NMDA receptors. Neurosci Lett 2012; 530: 121-126.
67. Kim J, Jung SY, Lee YK, Park S, Choi JS, Lee CJ et al. Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals. Proc Natl Acad Sci USA 2008; 105: 9087-9092.
68. Rogan MT, Staubli UV, LeDoux JE. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 1997; 390: 604-607.
69. Walker DL, Ressler KJ, Lu KT, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 2002; 22: 2343-2351.
70. Ledgerwood L, Richardson R, Cranney J. Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci 2003; 117: 341-349.
71. Ledgerwood L, Richardson R, Cranney J. D-cycloserine and the facilitation of extinction of conditioned fear: Consequences for reinstatement. Behav Neurosci 2004; 118: 505-513.
72. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E et al. Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004; 61: 1136-1144.
73. Yang YL, Lu KT. Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala. Neuroscience 2005; 134: 247-260.
74. Litz BT, Salters-Pedneault K, Steenkamp MM, Hermos JA, Bryant RA, Otto MW et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res 2012; 46: 1184-1190.
75. Difede J, Cukor J, Wyka K, Olden M, Hoffman H, Lee FS et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress dis¬order: A pilot randomized clinical trial. Neuropsychopharmacology 2014; 39: 1052-1058.
76. de Kleine RA, Hendriks G-J, Kusters WJ, Broekman TG, van Minnen A. A rando¬mized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry 2012; 71: 962-968.
77. Scheeringa MS, Weems CF. Randomized placebo-controlled D-Cycloserine with cognitive behavior therapy for pediatric posttraumatic stress. J Child Adolesc Psychopharmacol 2014; 24: 69-77.
78. Rothbaum BO, Price M, Jovanovic T, Norrholm SD, Gerardi M, Dunlop B et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry 2014; 171: 640-648.
79. Hood WF, Compton RP, Monahan JB. D-cycloserine: A ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 1989; 98: 91-95.
80. Billard JM, Rouaud E. Deficit of NMDA receptor activation in CA1 hippocampal area of aged rats is rescued by D-cycloserine. EurJ Neurosci 2007; 25: 2260-2268.
81. Rouaud E, Billard JM. D-cycloserine facilitates synaptic plasticity but impairs glu-tamatergic neurotransmission in rat hippocampal slices. Br J Pharmacol 2003; 140: 1051-1056.
82. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459: 569-573.
83. Bennett AOM. Dual constraints on synapse formation and regression in schizo¬phrenia: Neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin. Aust NZ J Psychiatry 2008; 42: 662-677.